应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
NVS 诺华
盘后交易 10-20 16:28:17 EDT
153.64
+3.44
+2.29%
盘后
153.64
+0.00
0.00%
16:15 EDT
最高
153.68
最低
151.95
成交量
135.69万
今开
152.15
昨收
150.20
日振幅
1.15%
总市值
2,931亿
流通市值
2,844亿
总股本
19.08亿
成交额
2.08亿
换手率
0.07%
流通股本
18.51亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
财报前瞻 | 诺华本季度营收预计增4.00%,机构观点偏谨慎
财报Agent · 10-20 08:13
财报前瞻 | 诺华本季度营收预计增4.00%,机构观点偏谨慎
异动解读|诺华盘中上涨3.04%,FDA批准Rhapsido扩展至慢性皮肤病治疗
行情直击 · 10-15
异动解读|诺华盘中上涨3.04%,FDA批准Rhapsido扩展至慢性皮肤病治疗
异动解读|诺华盘中上涨3.02%,FDA批准Rhapsido扩展至慢性皮肤病治疗
行情直击 · 10-15
异动解读|诺华盘中上涨3.02%,FDA批准Rhapsido扩展至慢性皮肤病治疗
诺华印度批准通过配股筹资至多90亿卢比。
智通财经 · 10-08
诺华印度批准通过配股筹资至多90亿卢比。
美国FDA扩大诺华一款用于治疗慢性皮肤病的药物适应症
格隆汇 · 10-08
美国FDA扩大诺华一款用于治疗慢性皮肤病的药物适应症
诺华Rhapsido®获FDA批准 成为首款症状性皮肤划痕症治疗药物
智通财经 · 10-07
诺华Rhapsido®获FDA批准 成为首款症状性皮肤划痕症治疗药物
诺华制药(NVS)与艾博生物达成近78亿美元协议 共同推进RNA编码疗法研发
金吾财讯 · 10-02
诺华制药(NVS)与艾博生物达成近78亿美元协议 共同推进RNA编码疗法研发
美股异动 | 医药股上涨,礼来涨近4%
老虎资讯综合 · 09-24
美股异动 | 医药股上涨,礼来涨近4%
美股医药股逆市走高,礼来涨近4%,辉瑞涨超2%,默沙东、强生涨近2%,诺华制药、诺和诺德涨超1%;AI医疗概念股Temp
智通财经 · 09-24
美股医药股逆市走高,礼来涨近4%,辉瑞涨超2%,默沙东、强生涨近2%,诺华制药、诺和诺德涨超1%;AI医疗概念股Temp
市场消息:诺华制药公司获得人用药品委员会 对 COSENTYX® 治疗风湿性多肌痛 的积极意见。
智通财经 · 09-18
市场消息:诺华制药公司获得人用药品委员会 对 COSENTYX® 治疗风湿性多肌痛 的积极意见。
诺华制药(NVS.US):VHB937未达到其主要终点和次要终点。根据2期ASTRALS研究结果,已停止VHB937用于
格隆汇 · 09-16
诺华制药(NVS.US):VHB937未达到其主要终点和次要终点。根据2期ASTRALS研究结果,已停止VHB937用于
诺华宣布终止ALS药物VHB937的研发。
智通财经 · 09-16
诺华宣布终止ALS药物VHB937的研发。
诺华前中国总裁张颖加盟传奇生物,担任首席执行官
智通财经 · 09-15
诺华前中国总裁张颖加盟传奇生物,担任首席执行官
诺华接连两次III期失败的启示
蓝鲸财经 · 09-15
诺华接连两次III期失败的启示
异动解读|诺华盘中上涨3.19%,大股东施压改组董事会叠加机构上调评级提振反弹
行情直击 · 09-14
异动解读|诺华盘中上涨3.19%,大股东施压改组董事会叠加机构上调评级提振反弹
异动解读|诺华盘前上涨3.04%,大股东施压改组董事会叠加机构上调评级提振反弹
行情直击 · 09-14
异动解读|诺华盘前上涨3.04%,大股东施压改组董事会叠加机构上调评级提振反弹
诺华制药(NVS.US)大股东呼吁改组董事会,以改善公司治理。此前该公司股价因连续试验受挫于本周创下纪录跌幅。大股东Da
智通财经 · 09-10
诺华制药(NVS.US)大股东呼吁改组董事会,以改善公司治理。此前该公司股价因连续试验受挫于本周创下纪录跌幅。大股东Da
Artisan Partners:在药物试验接连受挫后 诺华应在董事会层面进行改组
格隆汇 · 09-10
Artisan Partners:在药物试验接连受挫后 诺华应在董事会层面进行改组
汇丰:将诺华制药的评级上调至“持有”,目标价110瑞士法郎。
智通财经 · 09-10
汇丰:将诺华制药的评级上调至“持有”,目标价110瑞士法郎。
心血管新药研发遇困局:诺华重磅临床折戟 Lp(a)指标降了但心血管疾病风险没降
每日经济新闻 · 09-09
心血管新药研发遇困局:诺华重磅临床折戟 Lp(a)指标降了但心血管疾病风险没降
加载更多
公司概况
公司名称:
诺华
所属市场:
NYSE
上市日期:
--
主营业务:
Novartis AG于1996年2月29日根据瑞士法律注册成立,为股份公司。公司是一家创新医药公司,从事研究、开发、制造、分销、营销和销售范围广泛的医药产品。它专注于核心治疗领域,包括心血管、肾脏和代谢疾病、免疫学、神经科学和肿瘤学。
发行价格:
--
{"stockData":{"symbol":"NVS","market":"US","secType":"STK","nameCN":"诺华","latestPrice":153.64,"timestamp":1792526400000,"preClose":150.2,"halted":0,"volume":1356871,"hourTrading":{"tag":"盘后","latestPrice":153.64,"preClose":153.64,"latestTime":"16:15 EDT","volume":10102,"amount":1552100.3737599999,"timestamp":1792527307782,"change":0,"changeRate":0,"amplitude":0.001985},"delay":0,"changeRate":0.022902796271637802,"floatShares":1851000000,"shares":1907999999,"eps":6.614734,"marketStatus":"盘后交易","change":3.44,"latestTime":"10-20 16:28:17 EDT","open":152.15,"high":153.68,"low":151.95,"amount":207829461.56478,"amplitude":0.011518,"askPrice":153.84,"askSize":1,"bidPrice":153,"bidSize":25,"shortable":3,"etf":0,"ttmEps":6.614734,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1792540800000},"marketStatusCode":4,"adr":1,"adrRate":1,"exchange":"NYSE","adjPreClose":150.2,"dividendRate":0.03037,"preHourTrading":{"tag":"盘前","latestPrice":152.09,"preClose":150.2,"latestTime":"09:29 EDT","volume":13619,"amount":2071632.66698,"timestamp":1792502965067,"change":1.89,"changeRate":0.012583,"amplitude":0.009055},"postHourTrading":{"tag":"盘后","latestPrice":153.64,"preClose":153.64,"latestTime":"16:15 EDT","volume":10102,"amount":1552100.3737599999,"timestamp":1792527307782,"change":0,"changeRate":0,"amplitude":0.001985},"volumeRatio":0.739402,"impliedVol":0.2992,"impliedVolPercentile":0.9283},"requestUrl":"/m/hq/s/NVS","defaultTab":"news","newsList":[{"id":"1176009370","title":"财报前瞻 | 诺华本季度营收预计增4.00%,机构观点偏谨慎","url":"https://stock-news.laohu8.com/highlight/detail?id=1176009370","media":"财报Agent","labels":["earningPreview"],"top":1,"itemType":null,"share":"https://www.laohunote.com/m/news/1176009370?lang=zh_cn&edition=full","pubTime":"2026-10-20 08:13","pubTimestamp":1792455209,"startTime":"0","endTime":"0","summary":"诺华将于2026年10月27日美股盘前发布最新季度财报,市场关切营收与盈利承压及管线催化的权衡。市场一致预期显示,本季度诺华营收预计为144.70亿美元,同比增长4.00%;调整后每股收益预计为2.29美元,同比增长2.73%;息税前利润预计为54.83亿美元,同比增长2.97%;公司未给出本季度毛利率与净利率的明确预测指引。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"财报前瞻 | 诺华本季度营收预计增4.00%,机构观点偏谨慎","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153941408","title":"异动解读|诺华盘中上涨3.04%,FDA批准Rhapsido扩展至慢性皮肤病治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=1153941408","media":"行情直击","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1153941408?lang=zh_cn&edition=full","pubTime":"2026-10-15 21:57","pubTimestamp":1792072664,"startTime":"0","endTime":"0","summary":"10月15日,诺华盘中上涨3.04%,报151.58美元,成交额5578.98万美元。消息面上,公司此前披露美国FDA批准Rhapsido用于经H1抗组胺药控制不佳的成人症状性皮肤划痕症患者,属于慢性皮肤病适应症扩展。该药物被描述为首款针对症状性皮肤划痕症的治疗产品,显示公司在免疫与皮肤疾病管线上的监管推进。考虑到公司此前多项临床项目接连受挫,此次获批有助于改善市场对其近期产品线执行力的预期。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"诺华获FDA新适应症批准,股价盘中上涨","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155464445","title":"异动解读|诺华盘中上涨3.02%,FDA批准Rhapsido扩展至慢性皮肤病治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=1155464445","media":"行情直击","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1155464445?lang=zh_cn&edition=full","pubTime":"2026-10-15 01:23","pubTimestamp":1791998592,"startTime":"0","endTime":"0","summary":"10月15日,诺华盘中上涨3.02%,报146.71美元,成交额1.25亿美元。消息面上,公司此前披露美国FDA批准Rhapsido用于经H1抗组胺药控制不佳的成人症状性皮肤划痕症患者,属于其慢性皮肤病适应症扩展。该药物被描述为首款针对症状性皮肤划痕症的治疗产品,反映诺华在免疫与皮肤疾病管线上的监管进展。相较此前多项临床受挫,此次获批有助于改善市场对其近期产品线执行力的预期。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"诺华获FDA新适应症批准,股价盘中上涨","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673008696","title":"诺华印度批准通过配股筹资至多90亿卢比。","url":"https://stock-news.laohu8.com/highlight/detail?id=2673008696","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673008696?lang=zh_cn&edition=full","pubTime":"2026-10-08 21:41","pubTimestamp":1791466872,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE0002141913.USD","BK4588","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","LU0320765489.SGD","PPH","IE00BJT1NW94.SGD","BK4578","LU0070302665.USD","MEDX","NVS","BK4007","LU0211331839.USD","IE0009355771.USD","LU0208291251.USD","BK4585","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673136042","title":"美国FDA扩大诺华一款用于治疗慢性皮肤病的药物适应症","url":"https://stock-news.laohu8.com/highlight/detail?id=2673136042","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673136042?lang=zh_cn&edition=full","pubTime":"2026-10-08 10:52","pubTimestamp":1791427935,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["MEDX","IE0009355771.USD","BK4007","BK4588","IE0002141913.USD","LU0320765489.SGD","BK4578","IE00B2B36J28.USD","LABU","NVS","BK4585","PPH","IE00BJT1NW94.SGD","BK4532","LU0070302665.USD","IE00BJJMRZ35.SGD","LU0208291251.USD","LU0211331839.USD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673011362","title":"诺华Rhapsido®获FDA批准 成为首款症状性皮肤划痕症治疗药物","url":"https://stock-news.laohu8.com/highlight/detail?id=2673011362","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673011362?lang=zh_cn&edition=full","pubTime":"2026-10-07 23:54","pubTimestamp":1791388472,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0070302665.USD","IE0002141913.USD","PPH","IE00BFTCPJ56.SGD","BK4585","IE00BJJMRZ35.SGD","LABU","LU0211331839.USD","LU0320765489.SGD","BK4578","IE00B2B36J28.USD","LU0208291251.USD","MEDX","IE00BJT1NW94.SGD","NVS","IE0009355771.USD","BK4532","BK4588","IE00B4R5TH58.HKD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672718579","title":"诺华制药(NVS)与艾博生物达成近78亿美元协议 共同推进RNA编码疗法研发","url":"https://stock-news.laohu8.com/highlight/detail?id=2672718579","media":"金吾财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2672718579?lang=zh_cn&edition=full","pubTime":"2026-10-02 16:17","pubTimestamp":1790929021,"startTime":"0","endTime":"0","summary":"金吾财讯 | 诺华制药 已与中国生物制药企业艾博生物达成一项重磅许可和选择权协议,共同推进RNA编码疗法的研发,交易潜在总金额高达近78亿美元。根据协议条款,艾博生物将获得5.75亿美元的首付款;若未来所有合作项目的选择权均被行使,艾博还将有资格获得最高约72亿美元的里程碑付款,以及未来产品销售的潜在特许权使用费。此外,诺华还将拥有独家选择权,可获得基于艾博专有RNA平台开发的更多下一代治疗资产的独家授权。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250107/MDhjNmU2MGE5ZmU5MzgyMDQ4NDM0MDU5MzkwMTYw.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/MDhjNmU2MGE5ZmU5MzgyMDQ4NDM0MDU5MzkwMTYw.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"306748","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0070302665.USD","IE00BJT1NW94.SGD","LU0211331839.USD","BK1574","NVS","PPH","BK4585","01477","LU0320765489.SGD","IE00BJJMRZ35.SGD","IE0009355771.USD","BK4578","MEDX","LU0208291251.USD","BK4588","BK4007","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","BK4532","IE00B2B36J28.USD","BK1191","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159199811","title":"美股异动 | 医药股上涨,礼来涨近4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1159199811","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1159199811?lang=zh_cn&edition=full","pubTime":"2026-09-24 22:23","pubTimestamp":1790259829,"startTime":"0","endTime":"0","summary":"9月24日,美股医药股上涨,礼来涨近4%,辉瑞涨超2%,默沙东、强生涨近2%,诺华、诺和诺德涨超1%。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765646.SGD","LU0912757837.SGD","LU0130517989.USD","LU2023250843.SGD","LU1941712348.USD","LU0225771236.USD","LU1221951129.SGD","IE00BJT1NW94.SGD","LU0456855351.SGD","LU2361045086.USD","LU0053666078.USD","LU2552382132.HKD","LU1989772923.USD","BGIA","LU0114720955.EUR","LU0882574139.USD","LU0320765059.SGD","LU0385154629.USD","LU0210528500.USD","LU1291159041.SGD","LU2168564149.EUR","LU2237438978.USD","LU2750360997.AUD","LU0203347892.USD","IE0004445015.USD","LU1093756325.SGD","LU1366192091.USD","LU0820561818.USD","LU2746668461.USD","LU0477156953.USD","SG9999003800.SGD","LU2324357040.USD","LU0980610538.SGD","LU2462591350.SGD","LU2491049909.HKD","LU0964807845.USD","LU0823416689.USD","LU1914381329.SGD","IE000SO60NU8.SGD","IE00B19Z3581.USD","LU0266013472.USD","LU0070302665.USD","LU0942090050.USD","LU0859254822.USD","LU1228905037.USD","MHIP","LU0553294199.USD","PFE","LU0256863902.USD","IE00BK4W5L77.USD","LU0820562030.AUD","IE00BFXG1179.USD","LU1023059063.AUD","LU2361044949.HKD","LU0426412945.USD","LU1732799900.SGD","LU2168564065.EUR","LU2756315318.SGD","OZEM","LU1979441026.SGD","LU2357305700.SGD","LU2505996509.AUD","LU0889565916.HKD","LU2592432038.USD","LU1162221912.USD","IE00BLSP4452.SGD","MEDX","LU0203201768.USD","LU2468319806.SGD","LU2403377893.USD","MEDI","LU2237443895.HKD","LU1988902786.USD","LU0795875086.SGD","LU1571399168.USD","SG9999011175.SGD","BMED","IE00B4R5TH58.HKD","LU2237443382.USD","LU1323610961.USD","LU0417517546.SGD","LU0345770308.USD","LU0109391861.USD","LU1074936037.SGD","LU1232071149.USD","LU0238689110.USD","LU1127390331.HKD","LU2023251221.USD","BK4599","LU2063271972.USD","LU1116320737.USD","LU2361044865.SGD","SGXZ31699556.SGD","THNR","IHE","BK4007","LU0058720904.USD","LU0985320562.USD","LU2108987350.USD","LU2360106947.USD","LU0096364046.USD","IE0000B7K699.USD","LU1629891620.HKD","LU2471134523.USD","LU1814569148.SGD","FTXH","LU0321505439.SGD","SG9999017495.SGD","LU0820561909.HKD","IE00B775H168.HKD","SGXZ57979304.SGD","LU0211331839.USD","LU0106261372.USD","IE0002270589.USD","LU0471298777.SGD","LLYX","LU1066051498.USD","LU1066051811.HKD","IE00B42XCP33.USD","SG9999001440.SGD","SG9999014575.USD","LU0345769631.USD","LU1804176565.USD","IE00B1BXHZ80.USD","LU0225283273.USD","LU0158827781.USD","PPH","NVO","BK4578","BK1161","LU2552382058.USD","MRK","LU2129689605.HKD","SG9999015341.SGD","LU1066051225.USD","LU2028103732.USD","TRUH","LU1201861249.SGD","LU0345769128.USD","LU1551013425.SGD","LU2271345857.HKD","LU1674673428.USD","IE00B3PB1722.GBP","LU1974910355.USD","LU0289961442.SGD","SG9999013999.USD","IE00BK4W5M84.HKD","LU1069347547.HKD","SG9999015986.USD","LU0432979614.USD","LU0345770993.USD","LU1868836757.USD","LU0256863811.USD","LU0061475181.USD","LU2213496289.HKD","SG9999014914.USD","LU1093756168.USD","LU1116320901.HKD","IE0034235303.USD","VHT","LU1061106388.HKD","LU1430594728.SGD","BK7104","LU1037948541.HKD","IE00BN8TJ469.HKD","LU0323591593.USD","LU1718418525.SGD","BK4559","LU2471134952.CNY","SG9999002224.SGD","LU0472753341.HKD","IXJ","LU2264538146.SGD","LU0965508806.USD","LU1496350502.SGD","LU0545562505.USD","LU2552382215.SGD","SG9999015952.SGD","LU0094547139.USD","LU0882574055.USD","LU1699723380.USD","LU0162691827.USD","LU0174119429.USD","LU0265550359.USD","LU0203202063.USD","LU0661504455.SGD","LU0198837287.USD","ILDR","LU0353189680.USD","LU1720051017.SGD","LU1720051108.HKD","BK4534","LU2111349929.HKD","LU2347655156.SGD","LU2129689431.USD","LU1548497426.USD","LU2433249047.HKD","LU0072461881.USD","LU2087625088.SGD","LU0823434740.USD","LU2357627491.SGD","IE00BVYPNV92.GBP","IE00B7SZLL34.SGD","LU0985481810.HKD","LU0354030511.USD","LU0124676726.USD","NVOC","LU1043141123.HKD","LU1868836591.USD","LU2360032135.SGD","SG9999002232.USD","LU2237443549.SGD","LU2505996681.GBP","LU0057025933.USD","SGXZ80539844.SGD","LU2125154935.USD","IE000WAW04H5.SGD","IE00BN29S564.USD","LU1934455863.HKD","LU1868837300.USD","LU1935042991.SGD","LU2237443978.SGD","JNJ","SG9999018857.SGD","LU1983299246.USD","LU1732800096.USD","LU1989771016.USD","IYH","TMED","LU0203345920.USD","LU1894683264.USD","LU1003077747.HKD","LU0795875169.SGD","SG9999001176.SGD","LU1035775433.USD","LU2491050154.USD","SG9999014567.USD","LU0689626769.HKD","BK4504","IE00B2B36J28.USD","LU0965509010.AUD","LU1069344957.HKD","LU1032955483.USD","IE00BGHQF631.EUR","LU2265009873.SGD","LU0289739343.SGD","LU0070217475.USD","IE000BZT7R73.USD","LU2089283258.USD","LU0320765992.SGD","LU1989772840.SGD","LU2237443465.HKD","NVS","LU1121112475.USD","LU1917777945.USD","LU1868836914.USD","LU0787776722.HKD","LU0786609619.USD","BK4592","HRTS","WDNA","LU1941712264.USD","LU1506573853.SGD","BK4585","IE00BVYPNW00.USD","LU2430703251.USD","PJP","LU2106854487.HKD","LU0466842654.USD","LU0320765489.SGD","LU0861579265.USD","IE0002141913.USD","LU0306807586.USD","LU0158827948.USD","LU0868494617.USD","LU2417539215.USD","SG9999015358.SGD","LU1585245621.USD","LU2430703178.SGD","LU1883839398.USD","LU0994945656.USD","SG9999001176.USD","IE00BJJMRX11.SGD","LU2456880835.USD","JDOC","LU1261432733.SGD","NVOX","LU1059921491.USD","LU1623119135.USD","LU0006306889.USD","FHLC","SG9999014906.USD","LU0889566641.SGD","IE00BZ1G4Q59.USD","LU0943347566.SGD","IE00BLSP4239.USD","LU1267930730.SGD","LU0289739699.SGD","LU0316494557.USD","SG9999015978.USD","BK4581","LLY","LU2168563687.JPY","LU0109394709.USD","LU1929549753.HKD","IE000MB6IJN5.SGD","LU2133065610.SGD","LU0545039389.USD","LU2125154778.USD","SG9999018865.SGD","IE00B7KXQ091.USD","LU0708995401.HKD","LU1221951046.USD","LU1551013342.USD","LU0353189763.USD","LU0208291251.USD","PAWZ","IE00BBT3K403.USD","IE00BKDWB100.SGD","IE000M9KFDE8.USD","IE0009355771.USD","LLII","IE0004445239.USD","LU0683600562.USD","LU2896262040.SGD","LU2746668974.SGD","LU1037948897.HKD","SG9999014542.SGD","BK4532","AGNG","LU0321505868.SGD","LU1032466523.USD","LU0792757196.USD","IE00BKPKM429.USD","LU2236285917.USD","LU0738911758.USD","RXL","LU0949170772.SGD","SGXZ99366536.SGD","CURE","LU2129689514.USD","LU0122379950.USD","LU2237443622.USD","IE00BSNM7G36.USD","IE00BWXC8680.SGD","LU0234572021.USD","LU2756315664.SGD","SGXZ81514606.USD","LU2487616109.SGD","LU1894683348.USD","LU1196500208.SGD","LU0170899867.USD","SGXZ51526630.SGD","IE00BKVL7J92.USD","LU0154236417.USD","LU0098860793.USD","LU1064131342.USD","LU2491050071.SGD","IE0001KFT4U8.USD","IE00BDGV0183.EUR","LU0225284248.USD","LU1228905540.USD","LU1244550221.USD","LU2211815571.USD","IE000F7OJYX1.SGD","LU0471298694.HKD","XLV","LU1280957306.USD","IE00BJJMRZ35.SGD","LU0234570918.USD","LU0672654240.SGD","LU2596442595.SGD","LU0648001328.SGD","IE00BJJMRY28.SGD","LU0210536198.USD","LU2461242641.AUD","SG9999014898.SGD","CANC","LU2023250330.USD","LU0689472784.USD","LU1712237335.SGD","LU0069063385.USD","LU0965509101.SGD","LU0133085943.USD","IE00BFSS8Q28.SGD","LU0354030438.USD","ELIL","SG9999014559.SGD","IE00BJLML261.HKD","LU2750360641.GBP","IE00B1XK9C88.USD","LU1691799644.USD","LU1674673691.USD","BK4588","LU0965509283.SGD","LLYZ","BK4516","LU2112291526.USD","BK1515","LU2125909247.SGD","LU0079474960.USD","BK1574","LU2168564222.USD","LU0426417589.USD","NVOH","BK4568","GDOC","GB00BDT5M118.USD","LU2602419157.SGD","IE00B3T34201.USD","LU2168564495.EUR","LU1267930813.SGD","LU2471134879.HKD","LU2125909593.SGD","BK7095","159938","SG9999015945.SGD","IE0005OL40V9.USD","LU0511384066.AUD","LU0306806265.USD","ELIS","LU0265550946.USD","LU1244550577.SGD","LU2430703095.HKD","LU1043141396.HKD","LABD","LU1244550494.USD","IE00B4JS1V06.HKD","LU1057294990.SGD","LU1934455277.USD","LU2089284900.SGD","LU1868837136.USD","LU1066053197.SGD","LU1035773651.USD","LU0097036916.USD","BK4550","IE00BFTCPJ56.SGD","LU1778281490.HKD","BK4533","LU0640476718.USD","LU1934455194.USD","LU2023250504.SGD","LU2462157665.USD","LU0823434583.USD","LU1145028129.USD","LU1923622614.USD","IE00B19Z3B42.SGD","SG9999014880.SGD","IE00BFSS7M15.SGD","LU0868494708.USD","LU2471134796.USD","LU2089984988.USD","LU0130102774.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669496056","title":"美股医药股逆市走高,礼来涨近4%,辉瑞涨超2%,默沙东、强生涨近2%,诺华制药、诺和诺德涨超1%;AI医疗概念股Temp","url":"https://stock-news.laohu8.com/highlight/detail?id=2669496056","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669496056?lang=zh_cn&edition=full","pubTime":"2026-09-24 22:19","pubTimestamp":1790259582,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1778281490.HKD","LU2237443465.HKD","OZEM","LU2468319806.SGD","LU1923622614.USD","LU1917777945.USD","LU0098860793.USD","LU0965509101.SGD","LU0472753341.HKD","IE00B3PB1722.GBP","LU2063271972.USD","LU1261432733.SGD","IE0034235303.USD","IE00B42XCP33.USD","LU0738911758.USD","BK4559","BK4588","LU2430703095.HKD","LU2552382058.USD","GB00BDT5M118.USD","LU0094547139.USD","LU0306807586.USD","LU0545562505.USD","LU2129689605.HKD","LU0070217475.USD","LU1116320901.HKD","BK4534","LU0354030438.USD","LU1023059063.AUD","LU2129689431.USD","LU2089984988.USD","LU0511384066.AUD","LU0985481810.HKD","LU0316494557.USD","SGXZ51526630.SGD","SG9999014906.USD","IE00B2B36J28.USD","LU2417539215.USD","LU0006306889.USD","SG9999014567.USD","LU0426417589.USD","LU0203201768.USD","LU1064131342.USD","LU1366192091.USD","LU2505996509.AUD","SGXZ31699556.SGD","SG9999018857.SGD","LU0965509010.AUD","LU1093756325.SGD","LU0158827781.USD","LU2357305700.SGD","LU1914381329.SGD","LU1061106388.HKD","LU0256863902.USD","LU0964807845.USD","SG9999002232.USD","LU0985320562.USD","LU0353189680.USD","LU0070302665.USD","LU0321505439.SGD","LU2746668974.SGD","LU2125909247.SGD","LU0466842654.USD","LU1929549753.HKD","LU1043141123.HKD","MEDI","SG9999001440.SGD","IE00BLSP4239.USD","LU2491050071.SGD","IE00B1BXHZ80.USD","LU0238689110.USD","SG9999011175.SGD","LU2750360641.GBP","LU0689472784.USD","SG9999001176.USD","LU0795875169.SGD","IE00BJJMRY28.SGD","LU0109394709.USD","LU0203202063.USD","LU2125154935.USD","SG9999015986.USD","SGXZ57979304.SGD","LU0323591593.USD","IE00BSNM7G36.USD","LLYX","LU0882574055.USD","LU0640476718.USD","LU0661504455.SGD","LU1571399168.USD","LU1674673691.USD","LU1989772840.SGD","LU2487616109.SGD","BK4585","LU0683600562.USD","LU0868494617.USD","LU1280957306.USD","JDOC","IE00BKDWB100.SGD","LU0949170772.SGD","IE00B7KXQ091.USD","LU1674673428.USD","LU0158827948.USD","CURE","LU0225284248.USD","LU1032466523.USD","LU0266013472.USD","LU0689626769.HKD","PJP","LU1989771016.USD","LU0345770993.USD","LU2471134879.HKD","LU0133085943.USD","LU2264538146.SGD","LU0417517546.SGD","MEDX","SG9999013999.USD","LU0385154629.USD","LU1691799644.USD","LU2089283258.USD","XLV","LU1121112475.USD","LU0058720904.USD","LU0477156953.USD","CANC","FTXH","PPH","LU2129689514.USD","PFE","LU2430703178.SGD","IE00BFSS8Q28.SGD","LU0265550946.USD","LU0545039389.USD","LU1244550577.SGD","IE00BVYPNV92.GBP","WDNA","LU1718418525.SGD","BK4592","LU0289739343.SGD","LU0868494708.USD","LU0079474960.USD","MHIP","SG9999014575.USD","LU2133065610.SGD","LU2347655156.SGD","LU0912757837.SGD","ELIS","IE000F7OJYX1.SGD","SG9999015945.SGD","IE0004445015.USD","IE000M9KFDE8.USD","IE00BJT1NW94.SGD","LU2125909593.SGD","LU0211331839.USD","IHE","LU1894683264.USD","LU0096364046.USD","LU0210528500.USD","LU0289961442.SGD","RXL","BK4007","LU0994945656.USD","LU1868837300.USD","ELIL","NVOC","LU2602419157.SGD","LU1066051811.HKD","LU1941712264.USD","LU2746668461.USD","LU0097036916.USD","LU2360032135.SGD","LU0432979614.USD","LU0174119429.USD","LU1093756168.USD","LU2087625088.SGD","IE0005OL40V9.USD","LU0648001328.SGD","LU0942090050.USD","LU0234572021.USD","LU0708995401.HKD","LU1323610961.USD","LU1585245621.USD","LU1720051108.HKD","LU1267930730.SGD","LU1074936037.SGD","BMED","LU1232071149.USD","LU0345770308.USD","LU0795875086.SGD","LU2168564149.EUR","LU0320765992.SGD","LU0053666078.USD","LU2237438978.USD","LU1221951046.USD","SG9999015952.SGD","IE00BVYPNW00.USD","LU0345769128.USD","LU1162221912.USD","LU0965509283.SGD","LU1196500208.SGD","LU1244550494.USD","LU1037948897.HKD","LU2456880835.USD","LU2089284900.SGD","LU1804176565.USD","LU1267930813.SGD","IE00B1XK9C88.USD","LU1228905037.USD","LU1127390331.HKD","LU0553294199.USD","LU2361045086.USD","BK4578","LU0889565916.HKD","LU0426412945.USD","SG9999001176.SGD","IE00BWXC8680.SGD","LU1043141396.HKD","LU1868836757.USD","BK4516","LU0943347566.SGD","LU1291159041.SGD","LU2471134523.USD","LU1548497426.USD","LU0456855351.SGD","TMED","LU2236285917.USD","LU0823434740.USD","LU1868837136.USD","IE00BZ1G4Q59.USD","LU2237443978.SGD","IE0000B7K699.USD","LU1551013342.USD","IE00BJLML261.HKD","ILDR","LU1228905540.USD","LU1883839398.USD","NVS","NVOX","LU2023250330.USD","LU0130102774.USD","LU0057025933.USD","LU0061475181.USD","LU1145028129.USD","MRK","LU1934455863.HKD","LU0354030511.USD","IE00B3T34201.USD","LU0672654240.SGD","LU0861579265.USD","IE00BK4W5M84.HKD","LU1941712348.USD","SG9999014914.USD","NVO","SG9999003800.SGD","LU2023251221.USD","LU2552382215.SGD","LU2896262040.SGD","SG9999002224.SGD","LU2505996681.GBP","LLYZ","LU0471298694.HKD","LU1989772923.USD","IE000SO60NU8.SGD","LU0170899867.USD","LU1983299246.USD","LU1988902786.USD","SG9999015358.SGD","SG9999015978.USD","LU1069347547.HKD","BK4504","LU1496350502.SGD","LU2125154778.USD","IE0009355771.USD","LU0265550359.USD","LU2461242641.AUD","LU1868836591.USD","LU2430703251.USD","SGXZ99366536.SGD","LU0321505868.SGD","LU0306806265.USD","LU1430594728.SGD","LU2361044865.SGD","LU0786609619.USD","LU0345769631.USD","LU2111349929.HKD","LU1979441026.SGD","IE00B4R5TH58.HKD","LU0203347892.USD","LU1066051498.USD","GDOC","IXJ","LU0130517989.USD","LU0289739699.SGD","LU0471298777.SGD","LU2491050154.USD","IE00BFXG1179.USD","LU0980610538.SGD","IE00BDGV0183.EUR","LU0320765646.SGD","LU2108987350.USD","THNR","LU1934455277.USD","LU0823434583.USD","LU2023250504.SGD","LU1712237335.SGD","LLII","LU2756315318.SGD","IE00BFTCPJ56.SGD","LU1894683348.USD","LU0208291251.USD","BK4550","LU1974910355.USD","LU1035773651.USD","BK4581","LU2552382132.HKD","LU2237443549.SGD","LU2462591350.SGD","LU2433249047.HKD","LU0162691827.USD","LU2237443382.USD","LU0210536198.USD","LU1934455194.USD","BK4533","IE00BKPKM429.USD","LU2357627491.SGD","IE00B19Z3581.USD","IE00BBT3K403.USD","LU1732800096.USD","SG9999014542.SGD","IE00B7SZLL34.SGD","LU0114720955.EUR","LU0198837287.USD","LU2592432038.USD","LU2168564495.EUR","LU2360106947.USD","LU0353189763.USD","LU1506573853.SGD","LU0820562030.AUD","LU2361044949.HKD","LU2324357040.USD","LU2213496289.HKD","LU2237443622.USD","LU0122379950.USD","LU2265009873.SGD","JNJ","SG9999014880.SGD","SG9999014898.SGD","LU1699723380.USD","LU1935042991.SGD","BK4599","BK4532","LU1069344957.HKD","SGXZ81514606.USD","SGXZ80539844.SGD","LU0320765489.SGD","FHLC","LU1720051017.SGD","IE0001KFT4U8.USD","IE00BFSS7M15.SGD","LU0320765059.SGD","IE0002270589.USD","LU2112291526.USD","LU0154236417.USD","LU1003077747.HKD","IE00BLSP4452.SGD","TRUH","LU1732799900.SGD","LU2168564222.USD","LU2596442595.SGD","LU2106854487.HKD","LU0072461881.USD","LU1623119135.USD","IE00B19Z3B42.SGD","LU2756315664.SGD","LU0820561818.USD","LU0859254822.USD","SG9999014559.SGD","LU0225283273.USD","LU2403377893.USD","LU1059921491.USD","LU1201861249.SGD","LU1814569148.SGD","IE00BN29S564.USD","LU0203345920.USD","IE000WAW04H5.SGD","LU2168564065.EUR","LU0820561909.HKD","LU0965508806.USD","LU0889566641.SGD","IE000MB6IJN5.SGD","LU1116320737.USD","LU2271345857.HKD","SG9999018865.SGD","SG9999017495.SGD","LU0124676726.USD","LU1066051225.USD","SG9999015341.SGD","LU2471134952.CNY","LU1629891620.HKD","LU1066053197.SGD","IE00BJJMRZ35.SGD","LU0225771236.USD","LU1221951129.SGD","IE0002141913.USD","LU2750360997.AUD","IYH","LU0069063385.USD","NVOH","IE0004445239.USD","LU1057294990.SGD","IE00BJJMRX11.SGD","LU1244550221.USD","LU2471134796.USD","AGNG","LU2168563687.JPY","IE00BGHQF631.EUR","LU0787776722.HKD","IE00BK4W5L77.USD","IE000BZT7R73.USD","HRTS","LU2237443895.HKD","LU2211815571.USD","LU2028103732.USD","LU0882574139.USD","LU1037948541.HKD","IE00BN8TJ469.HKD","LU0792757196.USD","BK4568","LU1035775433.USD","IE00B775H168.HKD","LU2023250843.SGD","IE00BKVL7J92.USD","LU1032955483.USD","LU1868836914.USD","LLY","LU0823416689.USD","LU2491049909.HKD","PAWZ","LU0256863811.USD","LU2462157665.USD","VHT","LU0234570918.USD","LU0109391861.USD","IE00B4JS1V06.HKD","LU0106261372.USD","LU1551013425.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668248219","title":"市场消息:诺华制药公司获得人用药品委员会 对 COSENTYX® 治疗风湿性多肌痛 的积极意见。","url":"https://stock-news.laohu8.com/highlight/detail?id=2668248219","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668248219?lang=zh_cn&edition=full","pubTime":"2026-09-18 22:52","pubTimestamp":1789743127,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0070302665.USD","LU0208291251.USD","IE0002141913.USD","BK4588","IE00B2B36J28.USD","LU0320765489.SGD","MEDX","IE00BFTCPJ56.SGD","BK4007","BK4578","IE00BJT1NW94.SGD","IE0009355771.USD","BK4532","IE00B4R5TH58.HKD","NVS","LU0211331839.USD","BK4585","IE00BJJMRZ35.SGD","PPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667898420","title":"诺华制药(NVS.US):VHB937未达到其主要终点和次要终点。根据2期ASTRALS研究结果,已停止VHB937用于","url":"https://stock-news.laohu8.com/highlight/detail?id=2667898420","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667898420?lang=zh_cn&edition=full","pubTime":"2026-09-16 23:39","pubTimestamp":1789573152,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["IE00BJT1NW94.SGD","LU0070302665.USD","MEDX","LU0211331839.USD","IE00BFTCPJ56.SGD","NVS","LU0208291251.USD","IE00B4R5TH58.HKD","BK4532","IE00B2B36J28.USD","BK4578","IE0002141913.USD","PPH","BK4588","IE00BJJMRZ35.SGD","BK4585","IE0009355771.USD","LU0320765489.SGD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667898585","title":"诺华宣布终止ALS药物VHB937的研发。","url":"https://stock-news.laohu8.com/highlight/detail?id=2667898585","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667898585?lang=zh_cn&edition=full","pubTime":"2026-09-16 20:43","pubTimestamp":1789562627,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["NVS","IE0009355771.USD","LU0211331839.USD","BK4588","BK4578","IE00BJT1NW94.SGD","IE0002141913.USD","BK4585","IE00BFTCPJ56.SGD","PPH","BK4532","LU0070302665.USD","LU0208291251.USD","IE00B4R5TH58.HKD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","BK4007","MEDX","LU0320765489.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667822647","title":"诺华前中国总裁张颖加盟传奇生物,担任首席执行官","url":"https://stock-news.laohu8.com/highlight/detail?id=2667822647","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667822647?lang=zh_cn&edition=full","pubTime":"2026-09-15 20:43","pubTimestamp":1789476228,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","IE00BFTCPJ56.SGD","BK4007","IE00BJT1NW94.SGD","BK4578","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","LU0211331839.USD","MEDX","LEGN","PPH","BK4585","BK4505","LU0320765489.SGD","IE0009355771.USD","NVS","MEMS","IE00B4R5TH58.HKD","MEDI","LU0070302665.USD","IE0002141913.USD","LU0208291251.USD","BK4532","CANC","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667611645","title":"诺华接连两次III期失败的启示","url":"https://stock-news.laohu8.com/highlight/detail?id=2667611645","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667611645?lang=zh_cn&edition=full","pubTime":"2026-09-15 14:28","pubTimestamp":1789453731,"startTime":"0","endTime":"0","summary":"先是Pelacarsen,诺华重金押注的Lp靶向药,在全球III期研究LpHORIZON中,未能显著降低患者的主要心血管事件风险。紧接着,全球首个抗体寡核苷酸偶联药物del-desiran,也在III期HARBOR研究中错失主要终点。短短几天,两次III期失败。两条路,代价都极其高昂,且都押注在一个刚刚被III期失败动摇过的生物学假设上。Pelacarsen的III期试验耗资数以亿计,8,323名患者付出了宝贵的时间与信任。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1788926737124467348","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["LU0070302665.USD","IE00B4R5TH58.HKD","LU0211331839.USD","NVS","LU0208291251.USD","BK4585","BK4578","IE00BJJMRZ35.SGD","BK4007","BK4532","MEDX","PPH","IE00BJT1NW94.SGD","BK4588","IE0009355771.USD","IE0002141913.USD","IE00B2B36J28.USD","LU0320765489.SGD","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178932017","title":"异动解读|诺华盘中上涨3.19%,大股东施压改组董事会叠加机构上调评级提振反弹","url":"https://stock-news.laohu8.com/highlight/detail?id=1178932017","media":"行情直击","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1178932017?lang=zh_cn&edition=full","pubTime":"2026-09-14 22:09","pubTimestamp":1789394945,"startTime":"0","endTime":"0","summary":"9月14日,诺华盘中上涨3.19%,报139.49美元/股,成交额7223.19万美元。消息面上,诺华前20大股东Artisan Partners公开呼吁改组董事会,其董事总经理David Samra指出公司需加强对并购的监督,矛头直指120亿美元Avidity收购案及此前已计提减值的MorphoSys收购案,市场将此解读为推动公司治理改善的积极信号。此前一周,诺华因pelacarsen心血管III期试验失败、DM1药物del-desiran III期未达主要终点等三项临床接连受挫,股价一度重挫逾13%,本次反弹系超跌后多重利好共振所致。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"诺华获机构力挺,股价强势反弹","news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143135324","title":"异动解读|诺华盘前上涨3.04%,大股东施压改组董事会叠加机构上调评级提振反弹","url":"https://stock-news.laohu8.com/highlight/detail?id=1143135324","media":"行情直击","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1143135324?lang=zh_cn&edition=full","pubTime":"2026-09-14 20:43","pubTimestamp":1789389800,"startTime":"0","endTime":"0","summary":"9月14日,诺华盘前上涨3.04%,报141.22美元,成交额446.23万美元。消息面上,诺华前20大股东Artisan Partners公开呼吁改组董事会,其董事总经理David Samra指出公司需加强对并购的监督,矛头直指120亿美元Avidity收购案及此前已计提减值的MorphoSys收购案。该股东施压被市场解读为推动公司治理改善的积极信号。与此同时,汇丰将诺华评级上调至\"持有\",目标价110瑞士法郎;加拿大皇家银行以120瑞士法郎目标价启动覆盖。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"诺华盘前上涨,大股东施压改组董事会","news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666622025","title":"诺华制药(NVS.US)大股东呼吁改组董事会,以改善公司治理。此前该公司股价因连续试验受挫于本周创下纪录跌幅。大股东Da","url":"https://stock-news.laohu8.com/highlight/detail?id=2666622025","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666622025?lang=zh_cn&edition=full","pubTime":"2026-09-10 18:25","pubTimestamp":1789035953,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4578","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","BK4532","LU0208291251.USD","IE00B4R5TH58.HKD","BK4007","LU0320765489.SGD","MEDX","IE0009355771.USD","PPH","BK4585","NVS","WCEO","BK4588","IE00BFTCPJ56.SGD","LU0070302665.USD","IE00BJT1NW94.SGD","SYLD","IE0002141913.USD","LU0211331839.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666562462","title":"Artisan Partners:在药物试验接连受挫后 诺华应在董事会层面进行改组","url":"https://stock-news.laohu8.com/highlight/detail?id=2666562462","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666562462?lang=zh_cn&edition=full","pubTime":"2026-09-10 18:23","pubTimestamp":1789035834,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["PPH","LU0320765489.SGD","BK4585","MEDX","LU0070302665.USD","IE00BJJMRZ35.SGD","NVS","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","LU0211331839.USD","IE0002141913.USD","BK4588","BK4578","IE0009355771.USD","LU0208291251.USD","BK4007","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666553725","title":"汇丰:将诺华制药的评级上调至“持有”,目标价110瑞士法郎。","url":"https://stock-news.laohu8.com/highlight/detail?id=2666553725","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666553725?lang=zh_cn&edition=full","pubTime":"2026-09-10 07:44","pubTimestamp":1788997467,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0070302665.USD","IE0002141913.USD","PPH","IE00BFTCPJ56.SGD","BK4585","IE00BJJMRZ35.SGD","LU0211331839.USD","LU0320765489.SGD","BK4578","IE00B2B36J28.USD","LU0208291251.USD","MEDX","IE00BJT1NW94.SGD","NVS","IE0009355771.USD","FXF","BK4532","BK4588","IE00B4R5TH58.HKD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666531862","title":"心血管新药研发遇困局:诺华重磅临床折戟 Lp(a)指标降了但心血管疾病风险没降","url":"https://stock-news.laohu8.com/highlight/detail?id=2666531862","media":"每日经济新闻","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666531862?lang=zh_cn&edition=full","pubTime":"2026-09-09 22:52","pubTimestamp":1788965533,"startTime":"0","endTime":"0","summary":"9月4日,诺华与Ionis合作开发的Lp(a)〔即:脂蛋白(a)——编者注〕靶向药物pelacarsen的Lp(a)HORIZONⅢ期临床试验公布结果。这款被行业寄予厚望的候选药物,虽能大幅降低Lp(a)水平,却未能显著降低心血管事件风险,给全球心血管创新药赛道投下了一片不确定性阴影。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609093869631090.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609093869631090.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["IE00B2B36J28.USD","MEDX","BK4578","IE0002141913.USD","NVS","LU0211331839.USD","IE00BJJMRZ35.SGD","IE0009355771.USD","BK4532","LU0208291251.USD","PPH","IE00BFTCPJ56.SGD","BK4588","BK4585","LU0070302665.USD","LU0320765489.SGD","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.novartis.com","stockEarnings":[{"period":"1week","weight":0.0442},{"period":"1month","weight":0.07},{"period":"3month","weight":-0.0239},{"period":"6month","weight":0.0195},{"period":"1year","weight":0.1428},{"period":"ytd","weight":0.0894}],"compareEarnings":[{"period":"1week","weight":-0.0149},{"period":"1month","weight":0.0063},{"period":"3month","weight":0.0243},{"period":"6month","weight":0.0777},{"period":"1year","weight":0.1537},{"period":"ytd","weight":0.124}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Novartis AG于1996年2月29日根据瑞士法律注册成立,为股份公司。公司是一家创新医药公司,从事研究、开发、制造、分销、营销和销售范围广泛的医药产品。它专注于核心治疗领域,包括心血管、肾脏和代谢疾病、免疫学、神经科学和肿瘤学。","yearOnYearQuotes":[{"month":1,"riseRate":0.423077,"avgChangeRate":-0.007884},{"month":2,"riseRate":0.461538,"avgChangeRate":-0.004502},{"month":3,"riseRate":0.5,"avgChangeRate":-0.002232},{"month":4,"riseRate":0.692308,"avgChangeRate":0.016763},{"month":5,"riseRate":0.692308,"avgChangeRate":0.0095},{"month":6,"riseRate":0.592593,"avgChangeRate":0.013169},{"month":7,"riseRate":0.666667,"avgChangeRate":0.01085},{"month":8,"riseRate":0.407407,"avgChangeRate":0.000139},{"month":9,"riseRate":0.666667,"avgChangeRate":0.007004},{"month":10,"riseRate":0.444444,"avgChangeRate":-0.010655},{"month":11,"riseRate":0.615385,"avgChangeRate":0.016411},{"month":12,"riseRate":0.692308,"avgChangeRate":0.020635}],"exchange":"NYSE","name":"诺华","nameEN":"Novartis AG"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"诺华(NVS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供诺华(NVS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"诺华,NVS,诺华股票,诺华股票老虎,诺华股票老虎国际,诺华行情,诺华股票行情,诺华股价,诺华股市,诺华股票价格,诺华股票交易,诺华股票购买,诺华股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"诺华(NVS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供诺华(NVS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}